Works by Dent, Gersham


Results: 15
    1

    Effective Practices for Enrolling Underrepresented Groups in Early Alzheimer's Disease Trials: Insights from the Aducanumab Program.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S8, p. 1, doi. 10.1002/alz.095729
    By:
    • Showell, Shardae;
    • Murphy, Jennifer;
    • Gillis, Cai;
    • Maserejian, Nancy N;
    • Mayuram, Sangeetha;
    • Wilson, Jenna;
    • Farrell, Aimee;
    • King, Katie;
    • DaCosta, Savine;
    • Wilson, Kate;
    • Lovelace, Kerry;
    • Vigario, Andrew;
    • Dawson, Katherine;
    • Dent, Gersham
    Publication type:
    Article
    2
    3
    4

    A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries.

    Published in:
    Journal of Clinical & Experimental Neuropsychology, 2010, v. 32, n. 9, p. 937, doi. 10.1080/13803391003596496
    By:
    • Silverstein, StevenM.;
    • Jaeger, Judith;
    • Donovan-Lepore, Anne-Marie;
    • Wilkniss, SandraM.;
    • Savitz, Adam;
    • Malinovsky, Igor;
    • Hawthorne, Danielle;
    • Raines, Shane;
    • Carson, Sarah;
    • Marcello, Stephanie;
    • Zukin, StephenR.;
    • Furlong, Stephen;
    • Dent, Gersham
    Publication type:
    Article
    5
    6

    Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1.

    Published in:
    Journal of Neurology, 2022, v. 269, n. 7, p. 3579, doi. 10.1007/s00415-022-10970-x
    By:
    • Laforce, Robert Jr;
    • Dallaire-Théroux, Caroline;
    • Racine, Annie M.;
    • Dent, Gersham;
    • Salinas-Valenzuela, Cristian;
    • Poulin, Elizabeth;
    • Cayer, Anne-Marie;
    • Bédard-Tremblay, Daphnée;
    • Rouleau-Bonenfant, Thierry;
    • St-Onge, Frédéric;
    • Schraen-Maschke, Susanna;
    • Beauregard, Jean-Mathieu;
    • Sergeant, Nicolas;
    • Puymirat, Jack
    Publication type:
    Article
    7
    8
    9
    10

    CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 8, p. 3379, doi. 10.1002/alz.12919
    By:
    • Nisenbaum, Laura;
    • Martone, Robert;
    • Chen, Tianle;
    • Rajagovindan, Rajasimhan;
    • Dent, Gersham;
    • Beaver, John;
    • Rubel, Carrie;
    • Racine, Annie;
    • He, Ping;
    • Harrison, Katie;
    • Dean, Robert;
    • Vandijck, Manu;
    • Haeberlein, Samantha Budd
    Publication type:
    Article
    11
    12
    13

    Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer's disease: Developments in clinical trials and cognitive assessment.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047259
    By:
    • Haeberlein, Samantha Budd;
    • von Hehn, Christian;
    • Tian, Ying;
    • Chalkias, Spyros;
    • Muralidharan, Kumar Kandadi;
    • Chen, Tianle;
    • Wu, Shuang;
    • Skordos, LeAnne;
    • Nisenbaum, Laura;
    • Rajagovindan, Raj;
    • Dent, Gersham;
    • Harrison, Katie;
    • Nestorov, Ivan;
    • Zhu, Ying;
    • Mallinckrodt, Craig;
    • Sandrock, Alfred
    Publication type:
    Article
    14
    15